Skip to main content
OpenTrials
Completed

NCT Number: NCT03050073

Choroidal Thickness Association With Primary Angle Closure

A chinese study shows that chinese population eyes with a primary angle closure have a greater choroidal thickness than normal eyes.The increase of choroidal thickness would be associated to this primary angle closure.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Choroidal Thickness

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Groupe Hospitalier Paris Saint Joseph

Paris, Île-de-France Region, 75014, France

About this study

Usual ophtalmic consultation for glaucoma with primary angle closure

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >18 years
  • Primary angle closure confirmed by gonioscopy
  • interpretable images for choroidal thickness measure
  • interpretable images by Ultra Bio Microscopy (UBM)

Exclusion criteria

  • Acute crisis for angle closure
  • Rethinopathy (diabetic or hypertensive)
  • Histories of intra-eye surgery
  • Great myopia
  • Hypermetropia
  • retinal pathology

Treatment and study plan

Primary outcomes

  1. change of choroidal thickness measurement by Imaging of the fundus oculi (OCT swept source)

    Time frame: Day 1 Day 30

Sponsors and collaborators

Lead sponsor

Fondation Hôpital Saint-Joseph

Other

Registry information

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Feb 10, 2017
Registry last updated
Aug 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.